Algeria vs Turkmenistan: Cause of death, by non-communicable diseases, ages 5-14
Algeria
41.6%
in 2021
Turkmenistan
40.7%
in 2021
Algeria rank
76th
Turkmenistan rank
79th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Algeria
- Turkmenistan
How they compare
Algeria currently reports 41.6% against 40.7% in Turkmenistan, a difference of 0.9%.
Across all 6 years both countries report, Algeria has been ahead every year.
Algeria ranks 76th and Turkmenistan ranks 79th of 185 countries.
Algeria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Algeria | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 39.8% | 30.2% | 9.6% | Algeria |
| 2010s | 44.4% | 38.8% | 5.5% | Algeria |
| 2020s | 43.9% | 39.9% | 4.0% | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Algeria or Turkmenistan?
- Algeria, at 41.6% against 40.7% in Turkmenistan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Algeria and Turkmenistan?
- 0.9%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Turkmenistan?
- 6 years are reported by both, from 2000 to 2021.
- How do Algeria and Turkmenistan rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Algeria ranks 76th and Turkmenistan ranks 79th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.